Literature DB >> 27698068

Cardioprotective Angiotensin-(1-7) Peptide Acts as a Natural-Biased Ligand at the Angiotensin II Type 1 Receptor.

Ségolène Galandrin1, Colette Denis1, Cédric Boularan1, Jacky Marie1, Céline M'Kadmi1, Claire Pilette1, Caroline Dubroca1, Yvan Nicaise1, Marie-Hélène Seguelas1, Du N'Guyen1, Jean-Louis Banères1, Atul Pathak1, Jean-Michel Sénard1, Céline Galés2.   

Abstract

Hyperactivity of the renin-angiotensin-aldosterone system through the angiotensin II (Ang II)/Ang II type 1 receptor (AT1-R) axis constitutes a hallmark of hypertension. Recent findings indicate that only a subset of AT1-R signaling pathways is cardiodeleterious, and their selective inhibition by biased ligands promotes therapeutic benefit. To date, only synthetic biased ligands have been described, and whether natural renin-angiotensin-aldosterone system peptides exhibit functional selectivity at AT1-R remains unknown. In this study, we systematically determined efficacy and potency of Ang II, Ang III, Ang IV, and Ang-(1-7) in AT1-R-expressing HEK293T cells on the activation of cardiodeleterious G-proteins and cardioprotective β-arrestin2. Ang III and Ang IV fully activate similar G-proteins than Ang II, the prototypical AT1-R agonist, despite weaker potency of Ang IV. Interestingly, Ang-(1-7) that binds AT1-R fails to promote G-protein activation but behaves as a competitive antagonist for Ang II/Gi and Ang II/Gq pathways. Conversely, all renin-angiotensin-aldosterone system peptides act as agonists on the AT1-R/β-arrestin2 axis but display biased activities relative to Ang II as indicated by their differences in potency and AT1-R/β-arrestin2 intracellular routing. Importantly, we reveal Ang-(1-7) a known Mas receptor-specific ligand, as an AT1-R-biased agonist, selectively promoting β-arrestin activation while blocking the detrimental Ang II/AT1-R/Gq axis. This original pharmacological profile of Ang-(1-7) at AT1-R, similar to that of synthetic AT1-R-biased agonists, could, in part, contribute to its cardiovascular benefits. Accordingly, in vivo, Ang-(1-7) counteracts the phenylephrine-induced aorta contraction, which was blunted in AT1-R knockout mice. Collectively, these data suggest that Ang-(1-7) natural-biased agonism at AT1-R could fine-tune the physiology of the renin-angiotensin-aldosterone system.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  G-protein–coupled receptor; angiotensin 1-7; angiotensin II type 1 receptor; biased agonism; renin–angiotensin system; β-arrestin

Mesh:

Substances:

Year:  2016        PMID: 27698068     DOI: 10.1161/HYPERTENSIONAHA.116.08118

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  35 in total

Review 1.  Fetal programming and the angiotensin-(1-7) axis: a review of the experimental and clinical data.

Authors:  Andrew M South; Hossam A Shaltout; Lisa K Washburn; Alexa S Hendricks; Debra I Diz; Mark C Chappell
Journal:  Clin Sci (Lond)       Date:  2019-01-08       Impact factor: 6.124

Review 2.  Significance of angiotensin 1-7 coupling with MAS1 receptor and other GPCRs to the renin-angiotensin system: IUPHAR Review 22.

Authors:  Sadashiva S Karnik; Khuraijam Dhanachandra Singh; Kalyan Tirupula; Hamiyet Unal
Journal:  Br J Pharmacol       Date:  2017-03-09       Impact factor: 8.739

3.  125I-Angiotensin 1-7 binds to a different site than angiotensin 1-7 in tissue membrane preparations.

Authors:  Filipe F Stoyell-Conti; Sarin Itty; Christy Abraham; Katya Rigatto; Crystal A West; Robert C Speth
Journal:  Endocrine       Date:  2021-01-07       Impact factor: 3.633

4.  Mir-513a-3p contributes to the controlling of cellular migration processes in the A549 lung tumor cells by modulating integrin β-8 expression.

Authors:  Marina Bonfogo da Silveira; Kelvin Furtado Lima; Andrea Renata da Silva; Robson Augusto Souza Dos Santos; Karen C M Moraes
Journal:  Mol Cell Biochem       Date:  2017-12-04       Impact factor: 3.396

5.  MAS1 Receptor Trafficking Involves ERK1/2 Activation Through a β-Arrestin2-Dependent Pathway.

Authors:  Flavia M Cerniello; Oscar A Carretero; Nadia A Longo Carbajosa; Bruno D Cerrato; Robson A Santos; Hernán E Grecco; Mariela M Gironacci
Journal:  Hypertension       Date:  2017-09-05       Impact factor: 10.190

6.  Modulating Role of Ang1-7 in Control of Blood Pressure and Renal Function in AngII-infused Hypertensive Rats.

Authors:  Marta Kuczeriszka; Elzbieta Kompanowska-Jezierska; Janusz Sadowski; Minolfa C Prieto; L Gabriel Navar
Journal:  Am J Hypertens       Date:  2018-03-10       Impact factor: 2.689

Review 7.  G Protein-Coupled Receptor Signaling Through β-Arrestin-Dependent Mechanisms.

Authors:  Pierre-Yves Jean-Charles; Suneet Kaur; Sudha K Shenoy
Journal:  J Cardiovasc Pharmacol       Date:  2017-09       Impact factor: 3.105

8.  Diminazene aceturate prevents nephropathy by increasing glomerular ACE2 and AT2 receptor expression in a rat model of type1 diabetes.

Authors:  Santosh Kumar Goru; Almesh Kadakol; Vajir Malek; Anuradha Pandey; Nisha Sharma; Anil Bhanudas Gaikwad
Journal:  Br J Pharmacol       Date:  2017-08-11       Impact factor: 8.739

9.  GHSR-D2R heteromerization modulates dopamine signaling through an effect on G protein conformation.

Authors:  Marjorie Damian; Véronique Pons; Pedro Renault; Céline M'Kadmi; Bartholomé Delort; Lucie Hartmann; Ali I Kaya; Maxime Louet; Didier Gagne; Khoubaib Ben Haj Salah; Séverine Denoyelle; Gilles Ferry; Jean A Boutin; Renaud Wagner; Jean-Alain Fehrentz; Jean Martinez; Jacky Marie; Nicolas Floquet; Céline Galès; Sophie Mary; Heidi E Hamm; Jean-Louis Banères
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-09       Impact factor: 11.205

Review 10.  Dimerization of AT2 and Mas Receptors in Control of Blood Pressure.

Authors:  Sanket Patel; Tahir Hussain
Journal:  Curr Hypertens Rep       Date:  2018-05-01       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.